Andy Yoo

Andy Yoo is recorded as CEO at Exicure, Inc. (XCUR) since December 17, 2024 and Board Member at Exicure, Inc. (XCUR) since November 21, 2024. Exicure, Inc. reported in an 8-K filed February 17, 2026 that Andy Yoo resigned as Chief Executive Officer and President, effective February 9, 2026. Exicure, Inc. reported in an 8-K filed February 10, 2026 that Andy Yoo resigned as Chief Executive Officer and President, effective February 9, 2026. Exicure, Inc. reported in an 8-K filed February 10, 2026 that Andy Yoo resigned as Board of Directors, effective February 9, 2026. Equibles holds 7 filed executive changes naming Andy Yoo; each is listed under recent activity with its source filing. The proxy statement of Exicure, Inc. reports total compensation of $27,167 for Andy Yoo in fiscal 2024, including a base salary of $25,000. Exicure, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exicure, Inc. includes Brian C. Bock (CEO, CFO and Board Member), Jung Sang (Michael) Kim (CEO, CFO and Board Member), Jung Soo Kim (CEO and Board Member) and 7 others.